Early Age Onset Colorectal Cancer Activating Advocacy 1 st Never Too Young Forum June 9, 2016 Louisville, KY Louisville, KY Whitney F. Jones, M.D. KickingButt.org.

Slides:



Advertisements
Similar presentations
2004 Camden County Cancer Capacity and Needs Assessment: The Next Steps Jean F. Mouch, MD, MPH Camden County Coalition Coordinator April 6, 2005.
Advertisements

1 An Update on Evolving Colorectal Screening Issues May 19, 2011 This first part today will be presented by: Stanley H. Weiss, MD, FACP, FACE  Professor,
Spotlight on Colorectal Cancer Screening 1 1. Home Screening for Colon Cancer
Screening for Colorectal Cancer Cancer Symposium: Measuring the Benefits of Screening and Treatment October 2007.
What is cancer? A group of 100 different diseases The uncontrolled, abnormal growth of cells Cancer may spread to other parts of the body Source:
USPSTF Screening Recommendations: Implications for Adults at Higher Risk NYFAHC Roundtable, June 18, 2013 Robert A. Smith, PhD Senior Director, Cancer.
BECOMING PART OF THE PCCNC Our Vision: By working together the citizens of North Carolina will see a day when prostate cancer is no longer a threat to.
A few thoughts on cancer and cancer family syndromes Pamela McGrann, MD. Department of Medical Genetics.
The Burden of Cancer and an Action Plan for Change in Monroe County January 2013 Byron Kennedy, MD, PhD, MPH Deputy Director of Health Monroe County, NY.
Sex Differences in the Prevalence and Correlates of Colorectal Cancer Testing: Health Information National Trends Survey Sally W. Vernon 1, Amy.
Introduction Presentation Overview I.What is colon cancer? II.Reduce your risk III. How to find a screening facility IV. Patient resources V.Get involved.
The Wall Street Analyst Forum’s 17 th Annual Analyst Conference.
Introduction of Cancer Molecular Epidemiology Zuo-Feng Zhang, MD, PhD University of California Los Angeles.
April 6, o What is cancer? o Cancer statistics o Cancer prevention and early detection o Cancer disparities o Cancer survivorship o Cancer research.
Otis W. Brawley, M.D. Chief Medical and Scientific Officer Executive Vice President American Cancer Society Professor of Hematology, Medical Oncology,
Colorectal cancer: How do we approach health disparities? Marta L. Davila, MD, FASGE University of Texas MD Anderson Cancer Center.
The Facts about Breast Cancer
Colorectal Cancer Screening John Pelzel MD Sleepy Eye Medical Center.
Geriatric Health Maintenance: Cancer Screening Linda DeCherrie, MD Geriatric Fellow Mount Sinai Hospital.
Health Promotion and Disease Prevention-focus on Cancer Edward Anselm, MD Assistant Professor of Medicine Icahn School of Medicine at Mount Sinai Medical.
Cancer Program Fewer Montanans experience late stage cancer. Fewer Montanans die of cancer. Metrics Biannual percent of Montanans who are up-to-date with.
Cancer 101: A Cancer Education and Training Program for American Indians & Alaska Natives Cancer 101: A Cancer Education and Training Program for American.
M Ravanbod Medical oncologist Bushehr – 11/91 A 50 y/o white man comes for check up and wants to discuss about prostate cancer. Negative family history.
 You can participate if :  You have cancer, including breast, ovarian, and other cancers, or  Your family members have cancer including breast, ovarian,
Integrated Cancer Screening Education Modules.  A disease that starts in the cells  Genes inside cells order growth, work, reproduction and death What.
High risk population in GI field how we can find them? Ahmad Shavakhi MD Associate professor of gastroenterology.
Our Vision – Healthy Kansans Living in Safe and Sustainable Environments.
Health Care Reform Through the Cancer Lens State and Private Sector Reforms for Hispanic Healthcare Edward E. Partridge, MD National Board President American.
Slides last updated: June 2015 CRC: CLINICAL FEATURES.
INCIDENCE AND SURVIVAL TRENDS OF COLORECTAL CANCER FROM 2002 TO 2011 BE Ansa; E Alema-Mensah; MD Claridy; JQ Sheats; B Fontenot, and SA Smith Georgia Regents.
1 Colorectal Cancer # 2 Cancer Killer # 2 Cancer Killer SCREENING SAVES LIVES.
1 Colorectal Cancer # 2 Cancer Killer # 2 Cancer Killer SCREENING SAVES LIVES.
Grace and Alanah. National Health Priority Areas. Cancer.
“The African American Prostate Cancer Crisis in Numbers”
Universal Screening for Lynch Syndrome with Cascade Screening for Relatives September 7, 2012 Deb Duquette, MS, CGC Michigan Department of Community Health.
CANCER CONTROL NHPA’s. What is it? Cancer is a term to describe a diverse group of diseases in which some of the cells in body become defective. The following.
Cancer Prevention Eyad Alsaeed, MD,FRCPC Consultant Radiation Oncology PSHOC KFMC.
Cancer Mortality Target Measuring and Monitoring at a National Level Jennifer Benjamin, Department of Health Kathy Elliott, National Cancer Action Team.
A Clinical Profile of Male Health in the Bahamas “Real Men Die from Prostate Cancer” A Clinical Profile of Male Health in the Bahamas “Real Men Die from.
Worship in Pink Sunday.
Colorectal Cancer Screening Colorectal Cancer Screening VT SGNA Conference VT SGNA Conference October 24, 2015 October 24, 2015 Lynn Butterly, MD Lynn.
A Project of the Washington CARES About Cancer Partnership AND.
Colorectal Cancer Preventa ble Beata ble Treata ble.
Definition Signs & symptoms Treatment Root of the disease.
Printed by Natural History of Sun Protection Behaviors in a Cohort of Children in Colorado Nancy L. Asdigian PhD,* Lori A. Crane.
Do you have 3 or more affected relatives? (2 or less)
Camden & Islington Practice Nurse/HCA Event Gali Siegal Health Professional Engagement Facilitator Haringey and Enfield March 2016.
Trends in Colorectal Cancer Incidence Rates by Race, Age and Indices of Access to Medical Care in the U.S., Yongping Hao, PhD 1 Ahmedin Jemal,
COLON CANCER IN KENTUCKY PARTNERSHIPS & POLICY FOR SUSTAINABILITY Katie Bathje Kentucky Cancer Consortium presented to the Colon Cancer Prevention Project’s.
Colon Cancer. What is Colon Cancer?  Cancer that begins in the colon or rectum  The colon and rectum are both parts of the large intestine  The third.
2007 Pan American Health Organization 2004 Pan American Health Organization Malaria in the Americas: Progress, Challenges, Strategies and Main Activities.
1234 “FIT” IT IN! Make time to ensure your patients get screened for colon cancer.
The Elliott Breast Center * Baton Rouge, LA *
1 Kentucky Cancer Consortium: Exploring a lung cancer prevention and control network.
BREAST SELF- AWARENESS FOR OUR COMMUNITY Updated 3/2015.
Hereditary Cancer Predisposition: Updates in Genetic Testing
CRC 101; Part One Julie Banahan, RN, BSN, OCN
CRC 101; Part One Julie Banahan, RN, BSN, OCN
Colorectal Cancer Screening Guidelines
A Few Facts About Breast Cancer
Evidence of a Program's Effectiveness in Improving Colorectal Cancer Screening Rates in Federally Qualified Health Centers Robert L. Stephens, PhD, MPH1;
#BlackHealthMatters: Improving Breast Cancer Outcomes for Black Women
Survivors Teaching Students: Saving Women’s LivesSM
Dr James Carlton, Medical Adviser
Module 4: Colorectal Cancer
Dennis J. Ahnen, MD, Sally W. Wade, MPH, Whitney F
AAMC CCN Colorectal Cancer Screening Integrated Care Pathway
Cervical Cancer Surveillance, Screening, and Treatment
Colorectal cancer survival disparities in California
Genomic Medicine in Community Health: Protecting Human Rights
Presentation transcript:

Early Age Onset Colorectal Cancer Activating Advocacy 1 st Never Too Young Forum June 9, 2016 Louisville, KY Louisville, KY Whitney F. Jones, M.D. KickingButt.org

CRC > 55 Incidence and Mortality Trends ~1990s 2011 CRC EAO CRC Per 100,000 years

EAO CRC: On the Rise  64,068 cases between 1998 – 2007 reviewed  Increasing incidence Annual percentage change [APC] Annual percentage change [APC] Rectal cancers 3.9% (95% CI 3.1% to 4.7%) Rectal cancers 3.9% (95% CI 3.1% to 4.7%) Colon cancers 2.7% (95% CI 2% to 3.3%) Colon cancers 2.7% (95% CI 2% to 3.3%)  Median age for Y-CRC was 44 years, with most (75.2%) occurring between ages 40 and 49 years  Mucinous/signet cell pathology  Distal colon and rectum Yi-Qian Nancy You, MD, Archives of Internal Medicine, Letter, 2011 Cancer Epidemiol Biomarkers Prev.Cancer Epidemiol Biomarkers Prev Jun;18(6): doi: / EPI

EAO CRC vs CRC: disparity demographics  Nonwhite race/ethnicity (29.5% versus 17.6%, P<.001)  Uninsured or insured by Medicaid (16.5% versus 4.7%, P<.001) and who lived in the  Southern and western parts of the U.S. (56.2% versus 50.3%, P<.001)  Advanced stage disease Rectal 57% Rectal 57% Colon 63% Colon 63% Yi-Qian Nancy You, MD, Archives of Internal Medicine, Letter, 2011

What are the Characteristics of Under 50 CRC?  Average age diagnosed CRC is 71, giving the impression it's something that mainly affects the elderly,  CRC up by 2% annually in men and women under age 50 since 1992  Rectal cancer up 3.5% annually in men and 2.9% annually in women over same period. Now 20% rectal cancer are under age 50 Cancer Epidemiol Biomarkers Prev.Cancer Epidemiol Biomarkers Prev Jun;18(6): doi: / EPI

Predisposition Genetic syndromes FAP, HNPCC, etc Family history IBD EAO CRC Risk Factors SporadicWhoWhat/whereWhenWhy 30% 70%

“Founders Genes” aka Lynch Syndrome German immigrant family, Pennsylvania in the early 1700s. Movements of family from Pennsylvania through North Carolina, Alabama, Kentucky, Missouri, Iowa, Nebraska, Utah, Texas, and California Incomplete penetrance and variable expressivity Gene incidence may be much higher

EAO CRC Incidence and Mortality Behavioral factors CommunicationDisparities Public health Policy Late adoption to change Biological factors GeneticsEnvironmentMacroMicro Tumor biology +

Supply Chain of Cancer Prevention and Early Detection Research Awareness Screening EAO CRC?

Genetic testing Improved Fecal Testing Behavioral Communication Strategy to Address Disparities < 50 Screening Strategies Risk Modification - Research Environmental Tumor biology Hybrid Screening Strategies Addressing EAO CRC 2013

Advocacy: Why? To create change.  Our priorities Prevention Prevention Early detection Early detection Treatment (advanced disease) Treatment (advanced disease)  Do our investments match priorities?  Do we accept a year timeline?  Who is left out? Uninsured /underinsured Uninsured /underinsured Age Age  What are our models? Cervical cancer Cervical cancer HIV/AIDS HIV/AIDS

 Where is our current national strategy on colon cancer prevention through awareness and screening?  Reaching too many people a little too early or Reaching too few people a little too late.

Advocacy To Create Change Advocacy To Create Change  Goals  Strategy Message Message Target Target  Tactics  Reduce unnecessary suffering/deaths from Y-CRC  P olicy Changes: Biological and behavioral research, C-change ( not incremental)  Engagement and persuasion, frame as disparity, survivors and stories. white papers  P. P. P. “A mind changed against it’s will is of the same opinion still.” W. Shakespeare

Who are our targets?  Patients  Providers Physicians Physicians Extenders Extenders  Systems Payers Payers Networks Networks NGO’s, advocacy groups NGO’s, advocacy groups  Guiding bodies ( ACS, USPTFS, etc)

Goals Regarding Y-CRC? Policy = Action  A policy from the USPTFS/ ACS/,societies that in support of the current screening strategy that the initial discussion of colon cancer prevention program begin no later that age 40.  A policy to immediately increase education to providers and the public of critical importance of BOTH: Timely family history + age appropriate screen Timely family history + age appropriate screen Early symptom evaluation Early symptom evaluation  A policy to increase BOTH resources and research in: Biological factors Biological factors Communication Communication Screening strategies for asymptomatic normal risk Screening strategies for asymptomatic normal risk

Communications Strategies: Unintended Consequences  “Earlier”  More asymptomatic people screened earlier than suggested age  Increase in diagnostic colonoscopy usage for GI symptoms  Increased costs with reduced cost effectiveness  Increased morbidity and complications from screenings  Current: 50  Importance of family history never discussed No up/out - reach opportunity  Lost educational opportunity regarding symptoms and risk Patient and provider less aware of symptoms or the need to promptly evaluate  No preconditioning for normal risk at 50  No reduction in 50-55yo age mortality  Average first time screen well beyond age 50

Hot off the press……..  National challenge to increase on time screening.  Lead time messaging and awareness Increased risk population Increased risk population Symptom + evaluation for sporadic Symptom + evaluation for sporadic Improve % on time screens for normal risk Improve % on time screens for normal risk  Addresses 75% of EAO CRC

Flush 50……..NOW  40 is the new 50  Hard stop educational intervention for all  Promotes current guidelines better  Advocacy can work again

The Rising Incidence of Young-Onset Colorectal Cancer: A Call to Action  Dennis J Ahnen, MD; Sally W Wade, MPH; Whitney F Jones, MD,4; Randa Sifri, MD; Jose Mendoza Silveiras, MD; Jasmine Greenamyer, MPH; Stephanie Guiffre, MPA; Jennifer Axilbund, MS; Andrew Spiegel, JD; Y Nancy You, MD, MHSc.  Mayo Clinic Proceedings, February 2014, volume 89, issue

Personal Challenges from EAO CRC Health/wellnessPhysical/emotional A chink in the armor Frustration FinancesCosts Career implications InsuranceRetirement FamilySpouse Young children Reproduction

Y-CRC Categories  Predisposition  Genetic syndromes FAP, HNPCC, etc FAP, HNPCC, etc  Family history with early screen indications  Inflammatory bowel disease  Sporadic Who What/where When Why

Outline  Update on CRC Under 50  Changing the Trend  Making Impactful Change  Challenges to the Patient

Challenges and Issues Faced by Young Survivors  Health, money and family  Economic - costs and decreased productivity  Interacting with children  Reproduction  Implication for career  Life insurance  How to get your voice heard  More kid issues, reproduction, life insurance,  Being frustrated that this is a 50 year old disease in the minds of public health and the public generally

Colon Cancer Hits Younger Adults Especially Hard, Study Finds Risk of advanced disease, death greater than for middle-aged patients October 1, 2013 RSS Feed PrintRSS Feed Print TUESDAY, Oct. 1 (HealthDay News) -- Younger adults with colorectal cancer that has spread (metastasized) to other areas of the body have a higher risk of disease progression and death than middle-aged patients, a new study finds. Dr. Christopher Lieu, assistant professor at the University of Colorado.

More Deaths in Young Colon Cancer Victims  news/news/articles/2013/10/01/colon- cancer-hits-younger-adults-especially- hard-study-finds

…….Trending……… Fighting Colon Cancer: Saving lives + Saving money Madisonville, KY March 2013 Whitney F. Jones, M.D. KickingButt.orgkentuckycancerfoundation.org

The Overlooked Disparity “Young (Y) –CRC” Colorectal cancer under 50 CCA National Meeting October 11-13, 2013 Miami, Florida Miami, Florida Whitney F. Jones, M.D. KickingButt.org

Y-CRC incidence and mortality  Biological factors  Genetics  Environment Macro Macro Micro Micro  Tumor biology  Behavioral factors  Communication  Disparities public health  Policy  Late adoption to change

Empower and impact  Panel: An Under 50 Diagnosis: Up Close and Personal  Moderators: Martha Raymond, MA, Colon Cancer Alliance  Challenges and Issues Faced by Young Survivors Whitney Jones, MD, Colon Cancer Prevention Project  Participate in a discussion about the unique experiences that surround those diagnosed under age 50. Gather information about the tools available to these patients and how to best utilize these tools.

Unintended Consequences: Begin “Earlier” Communication Strategy  More asymptomatic people will want to get their screenings earlier than suggested age  Increase in diagnostic colonoscopy usage for non cancer GI symptoms  Increased costs with reduced cost effectiveness  Increased morbidity and complications from colonoscopy complications